Medicare to cover expensive cancer cell therapies
FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam (Reuters) – The U.S. Centers for Medicare and Medicaid Services (CMS)…
by October Gallery
FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam (Reuters) – The U.S. Centers for Medicare and Medicaid Services (CMS)…
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Roche Holding said its Tecentriq drug…
GOMA, Congo (Reuters) – The second case of Ebola recorded in east Congo’s main city of Goma had a large family including 10 children and managed to infect several people…
GOMA, Congo (Reuters) – Congolese authorities were racing to contain an Ebola epidemic on Thursday, after a gold miner with a large family contaminated several people in the east’s main…
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – The European Medicine Agency’s Committee for…
GENEVA (Reuters) – The United States could bolster the battle against the Ebola virus in Democratic Republic of Congo by allowing more of its experts to travel to the outbreak…
NEW YORK (Reuters) – U.S. President Donald Trump is considering a sweeping executive order that would cut prices on virtually all branded prescription drugs sold to Medicare and other government…
FILE PHOTO: A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit Tessier/File Photo PARIS (Reuters) – French drugs and healthcare group…
FILE PHOTO: Anopheles minimus mosquitoes are pictured at a lab in the Public Health Ministry in Bangkok, Thailand, November 9, 2017. REUTERS/Athit Perawongmetha LONDON (Reuters) – Strains of malaria resistant…
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Novartis’s…